Released Oct 29, 2026, before the open
10-Q filed Oct 29, 2026, 29 days after period end · 0000070318-26-000050
Tenet Reports Strong Third Quarter 2026 Results;
The release| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $5.63B | $5.29B | $5.13B | $5.07B |
| Net Income | $1.22B | $579.00M | $681.00M | $266.00M |
Tenet Healthcare Corp · CIK 70318 · Engraved from SEC EDGAR
| EPS Diluted | $12.41 | $3.86 | $4.89 | $0.94 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenet reported third quarter 2026 net income available to common shareholders of $1.000 billion, or $12.41 per diluted share, with adjusted diluted EPS of $6.64 and Adjusted EBITDA of $1.355 billion.¶2¶3¶4
Under the RCM Agreements with CommonSpirit Health, Tenet recognized cumulative catch-up adjustments increasing contract termination revenue by $233 million and net operating revenues by $97 million in the third quarter of 2026.¶5¶6
Tenet repurchased 7.99 million shares of common stock for $1.615 billion in the nine months ended September 30, 2026, and in September 2026 completed a private placement of $2.0 billion of 6.250% senior notes due 2034.¶7¶8
Tenet raised its FY 2026 Adjusted EBITDA outlook to $5.05 billion to $5.20 billion and its Adjusted Free Cash Flow outlook to $2.825 billion to $3.125 billion.¶9